Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: A pooled analysis of three population-based case-control studies
نویسندگان
چکیده
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD 2 School of Public Health, The University of Sydney, Sydney, New South Wales, Australia 3 Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT 4 Mayo Clinic, College of Medicine, Rochester, MN 5 National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia 6 Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 7 Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, NIH, DHHS, Gaithersburg, MD 8 UNSW Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia 9 Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA 10 Department of Family Medicine and Karmanos Cancer Institute, Wayne State University, Detroit, MI
منابع مشابه
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
Caspases play a critical role in regulation of apoptosis, cell differentiation, inflammation, and innate immunity, and several are mutated or have altered expression in non-Hodgkin lymphoma (NHL). To study the impact of genetic variation in caspases on NHL risk, we analyzed tag single nucleotide polymorphisms (SNPs) in 12 caspase and related genes in 3 population-based case-control studies (194...
متن کاملPolymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.
Genetic variation in innate immunity may alter host-pathogen defence mechanisms and promote aberrant immune responses and non-Hodgkin lymphoma (NHL). To test this hypothesis, we investigated polymorphisms in innate immune genes in a pooled analysis of two population-based case-control studies of NHL from the San Francisco Bay Area (308 cases, 684 controls) and UK (596 cases, 758 controls). The ...
متن کاملDiagnosis and Treatment B non-Hodgkin Lymphoma with System Biology Approaches
Lymphomas are solid tumors of immune system and Non-Hodgkin Lymphomas (NHL) is the most prevalent lymphomas; with wide ranges of histological and clinical features, it is so difficult to identify them. Herein, various bioinformatics tools (such as gene differential expressions, epigenetics and protein analysis) employed to find new treatment approach for NHL based on gene expression variation b...
متن کاملGenetic Variations of Tumor Necrosis Factor –α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients
Objective(s): Non- Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL) are two main hematological malignances which have been driven from lymphoid tissue. Genetic polymorphisms in tumor necrosis factor-α (TNF-α) -308 and lymphotoxin-α (LT-α) +252 may affect their transcription and expression which leads to their high plasma level. The frequency of the TNF-α (-308) and LT-...
متن کاملHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
Background: Non-Hodgkin lymphoma (NHL) includes a wide range of diseases with different clinical and biological features. NHL is usually presented as localized or generalized lymphadenopathy. It has been suggested that the HLA class I and II are associated with susceptibility to NHL. Different ethnic groups have been found to have different HLA class I and II alleles which affect NHL. Objective...
متن کامل